Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug1488 | FITSTART+ PBI Wiki | 1.00 |
drug457 | BCG-Denmark Wiki | 0.71 |
drug3502 | Saline Wiki | 0.32 |
Name (Synonyms) | Correlation | |
---|---|---|
D000428 | Alcohol Drinking NIH | 0.41 |
D000437 | Alcoholism NIH | 0.38 |
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
FITSTART (Feedback Intervention Targeting Student Transitions and Risk Trajectories) is a parent-based social norms intervention that has been shown to reduce risky drinking in incoming first year students.This program uses normative feedback to correct parents overestimation of other parents negative alcohol-related parenting practices (e.g., number of drinks parents would permit their college student to consume). Theory and research suggests that correcting those common misperceptions can motivate parents to adjust their own behaviors (e.g., reducing the number of drinks they would permit), which, in turn, can impact college student drinking. Despite FITSTARTs success, the design of the program limits participation to only students who have parents who can attend on-campus orientation sessions during the summer months before the start of the Fall semester. To address this limitation and extend the previous work, the proposed randomized clinical trial (RCT) will evaluate the efficacy of an online adaptation of the FITSTART(+) PBI program. To examine the efficacy of the newly developed FITSTART+ PBI web app, the proposed RCT will use a longitudinal design to examine if students self-report drinking and related negative consequences during their first semester in college significantly differed between FITSTART+ PBI (intervention app) and a control version of the app. Self-reported drinking and consequences are expected to be lower amongst students with parents randomized to FITSTART+ PBI relative to those with parents randomized to the control app.
Description: Assesses number of drinks consumed during an average week over the past month
Measure: Change from Baseline Daily Drinking at 1 Month Time: baseline, 1 monthDescription: Assesses number of drinks consumed during an average week over the past month.
Measure: Change from Baseline Daily Drinking at 3 Months Time: baseline, 3 monthsDescription: Assesses reported frequency of negative alcohol outcomes over the past month
Measure: Change from Baseline Frequency of Alcohol Consequences at 1 Month Time: baseline, 1 monthDescription: Assesses reported frequency of negative alcohol outcomes over the past month
Measure: Change from Baseline Frequency of Alcohol Consequences at 3 Months Time: baseline, 3 monthsDescription: Assesses frequency and quantity of alcohol consumption over the past month
Measure: Change from Baseline Quantity/Frequency/Peak Alcohol Use at 1 Month Time: baseline, 1 monthDescription: Assesses frequency and quantity of alcohol consumption over the past month
Measure: Change from Baseline Quantity/Frequency/Peak Alcohol Use at 3 Months Time: baseline, 3 monthsDescription: Assesses frequency heavy episodic drinking events over the past month
Measure: Change from Baseline heavy episodic drinking at 1 Month Time: baseline, 1 monthDescription: Assesses frequency heavy episodic drinking events over the past month
Measure: Change from Baseline heavy episodic drinking at 3 Months Time: baseline, 3 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports